Courses

  • sfwd-courses

    Interactive patient case discussions in neuroblastoma immunotherapy

    Thank you for participating in this event held on September 28, 2022. Please tap “Take this Course” button to login…

  • sfwd-courses

    SMA Expert Exchange: Novel treatments in clinical practice | Oman (Pre-assessment test)

    Thank you for participating in this event being held on October 28 & 29, 2022, a 1.5-day programme comprising engaging…

  • sfwd-courses

    SMA Expert Exchange: Novel treatments in clinical practice | Prague (Pre-assessment)

    Thank you for participating in this event being held on September 9 & 10, 2022, a 1.5-day programme comprising engaging…

  • sfwd-courses

    SMA Expert Exchange: Novel treatments in clinical practice | Prague (Post-assessment and evaluation)

    Thank you for participating in this event held on September 9 & 10, 2022, a 1.5-day programme comprising engaging activities…

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease

    This activity is supported by an independent educational grant from Amicus Therapeutics Inc. Information

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease (1.00 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA…

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease (0.75 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA…

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease (0.50 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA…

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease (1.50 AMA PRA credits)

    Physician continuing medical education (AMA) The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA…

  • sfwd-courses

    Best practices and recent advances in the management of worsening heart failure

    This activity is supported by an independent educational grant from Bayer AG, Germany. Information

  • sfwd-courses

    A multidisciplinary conversation on the stories of women with Fabry disease

    This activity is supported by an independent educational grant from Amicus Therapeutics Inc.  

  • sfwd-courses

    Manejo de la atrofia muscular espinal en Latinoamérica a través del espectro de pacientes

    Esta actividad es posible gracias a la ayuda educativa independiente facilitada por Biogen MA, Inc. Esta actividad educativa no está…

  • sfwd-courses

    Test Course

  • sfwd-courses

    Diagnosis and management of SMA in older adolescents and adults

    This activity is supported by an independent educational grant from Biogen MA, Inc. This activity is expired.   CME Information

  • sfwd-courses

    Targeting KRAS in Advanced NSCLC

    This activity is supported by educational funding provided by Amgen. This activity is expired.   CME Information

  • sfwd-courses

    Expert perspectives and practical guidance on targeting MET in advanced NSCLC

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany. This activity is expired.   CME…

  • sfwd-courses

    Management of relapsed/refractory high-risk neuroblastoma

    Learn from leading experts how to integrate immunotherapy-based approaches into individualized treatment plans for patients with high-risk relapsed/refractory neuroblastoma. This…

  • sfwd-courses

    Management of relapsed/refractory high-risk neuroblastoma (1.00 AMA PRA credits)

    The Postgraduate Institute for Medicine designates this educational activity for up to 1.00 AMA PRA Category 1 Credit(s)™. Physicians should…

  • sfwd-courses

    Management of relapsed/refractory high-risk neuroblastoma (0.75 AMA PRA credits)

    The Postgraduate Institute for Medicine designates this educational activity for up to 1.00 AMA PRA Category 1 Credit(s)™. Physicians should…

  • sfwd-courses

    Management of relapsed/refractory high-risk neuroblastoma (0.25 AMA PRA credits)

    The Postgraduate Institute for Medicine designates this educational activity for up to 1.00 AMA PRA Category 1 Credit(s)™. Physicians should…